Hoffmann R - Search Results

1

Long-term clinical outcome of sirolimus-eluting stent implantation in metabolic syndrome and diabetes.

Almalla M, Schröder J, Deserno V, Vogt F, Koos R, Koch KC, Marx N, Hoffmann R. Almalla M, et al. Among authors: hoffmann r. J Invasive Cardiol. 2010 Jul;22(7):317-21. J Invasive Cardiol. 2010. PMID: 20603503

2

Impact of the metabolic syndrome on angiographic and clinical events after coronary intervention using bare-metal or sirolimus-eluting stents.

Hoffmann R, Stellbrink E, Schröder J, Grawe A, Vogel G, Blindt R, Kelm M, Radke PW. Hoffmann R, et al. Am J Cardiol. 2007 Nov 1;100(9):1347-52. doi: 10.1016/j.amjcard.2007.06.021. Epub 2007 Aug 9. Am J Cardiol. 2007. PMID: 17950788

3

Impact of metabolic syndrome on clinical and angiographic outcome after sirolimus-eluting stent implantation.

Stellbrink E, Schröder J, Grawe A, Goebbels R, Blindt R, Kelm M, Hoffmann R. Stellbrink E, et al. Among authors: hoffmann r. Coron Artery Dis. 2007 Dec;18(8):601-6. doi: 10.1097/MCA.0b013e3282f09066. Coron Artery Dis. 2007. PMID: 18004109

4

Results of interventional treatment of stress positive coronary artery disease.

Adamu U, Knollmann D, Alrawashdeh W, Almutairi B, Deserno V, Kleinhans E, Schäfer W, Hoffmann R. Adamu U, et al. Among authors: hoffmann r. Am J Cardiol. 2010 Jun 1;105(11):1535-9. doi: 10.1016/j.amjcard.2010.01.010. Epub 2010 Apr 8. Am J Cardiol. 2010. PMID: 20494657

5

Everolimus-eluting versus paclitaxel-eluting stents for treatment of bare metal stent restenosis.

Almalla M, Schröder JW, Pross V, Stegemann E, Marx N, Hoffmann R. Almalla M, et al. Among authors: hoffmann r. Am J Cardiol. 2011 Aug 15;108(4):518-22. doi: 10.1016/j.amjcard.2011.03.080. Epub 2011 May 31. Am J Cardiol. 2011. PMID: 21624553 Clinical Trial.

6

Effectiveness of everolimus-eluting stents in the treatment of drug-eluting stent versus bare-metal stent restenosis.

Almalla M, Pross V, Marx N, Hoffmann R. Almalla M, et al. Among authors: hoffmann r. Coron Artery Dis. 2012 Nov;23(7):492-6. doi: 10.1097/MCA.0b013e328358a58f. Coron Artery Dis. 2012. PMID: 22990414

7

Three-year follow-up after treatment of bare-metal stent restenosis with first-generation or second-generation drug-eluting stents.

Almalla M, Schröder JW, Pross V, Marx N, Hoffmann R. Almalla M, et al. Among authors: hoffmann r. Coron Artery Dis. 2013 Mar;24(2):165-70. doi: 10.1097/MCA.0b013e32835c8fb2. Coron Artery Dis. 2013. PMID: 23242011

8

Long-term outcome after angiographically proven coronary stent thrombosis.

Almalla M, Schröder J, Hennings V, Marx N, Hoffmann R. Almalla M, et al. Among authors: hoffmann r. Am J Cardiol. 2013 May 1;111(9):1289-94. doi: 10.1016/j.amjcard.2013.01.268. Epub 2013 Feb 12. Am J Cardiol. 2013. PMID: 23415513

9

Paclitaxel-eluting balloon versus everolimus-eluting stent for treatment of drug-eluting stent restenosis.

Almalla M, Schröder J, Pross V, Marx N, Hoffmann R. Almalla M, et al. Among authors: hoffmann r. Catheter Cardiovasc Interv. 2014 May 1;83(6):881-7. doi: 10.1002/ccd.25072. Epub 2013 Jul 3. Catheter Cardiovasc Interv. 2014. PMID: 23765557

10

Long-term assessment of a novel biodegradable paclitaxel-eluting coronary polylactide stent.

Vogt F, Stein A, Rettemeier G, Krott N, Hoffmann R, vom Dahl J, Bosserhoff AK, Michaeli W, Hanrath P, Weber C, Blindt R. Vogt F, et al. Among authors: hoffmann r. Eur Heart J. 2004 Aug;25(15):1330-40. doi: 10.1016/j.ehj.2004.06.010. Eur Heart J. 2004. PMID: 15288161

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,902 results

Search Page

Filters